OCRX
Ocera Therapeutics, Inc.
OCRX
OCRX
Delisted
OCRX was delisted on the 8th of December, 2017.
34 hedge funds and large institutions have $30.7M invested in Ocera Therapeutics, Inc. in 2015 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 11 increasing their positions, 10 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
34
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$492K | |
| 2 | +$282K | |
| 3 | +$258K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$171K |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
+$97.5K |
Top Sellers
| 1 | -$4.04M | |
| 2 | -$2.94M | |
| 3 | -$471K | |
| 4 |
SM
Sabby Management
Miami Beach,
Florida
|
-$355K |
| 5 |
AIS
AlphaOne Investment Services
West Chester,
Pennsylvania
|
-$270K |